eRapport

Optimizing Thrombectomy in Acute Ischemic Stroke Using Artificial Intelligence

Prosjekt
Prosjektnummer
2021005
Ansvarlig person
Anne Hege Nymoen Aamodt
Institusjon
Oslo universitetssykehus HF
Prosjektkategori
Doktorgradsstipend
Helsekategori
Stroke
Forskningsaktivitet
4. Detection and Diagnosis
Rapporter
2024
Data collection from Kalnes, OUS and VVHF has been completed with the first AI tool called StrokeSENS. The data er being analyzed and the results will be published in 2025. Next step is to test newer AI tools but we are waiting for HSØ to get these AI tools available.In the mean time the PhD candidate have been working with 3 manuscripts on MRI and AI, that will be published in 2025. The Significance of Subtle DWI Lesion Dynamics: A Comparative Analysis of Methods for Detecting DWI Reversal in Endovascular Stroke Treatment The Predictive Value of ADC for DWI Lesion Reversal After Rapid Endovascular Recanalization. Mapping DWI Signal Reversal and Long-Term Tissue Outcomes Following Endovascular Therapy in Acute Ischemic Stroke.

nei

2023
The main aim of the this prospective observational multi-center study is to organize and simplify the care pathway through a pragmatic approach to acute stroke imaging powered by cutting edge advances in image processing and artificial intelligence. The project is led from Oslo UH in collaboration with Østfold, Vestre Viken and Innlandet HT.Secondary aims: 1. To assess the diagnostic accuracy of mCTA in detection of medium and large vessel occlusion ischemic stroke using AI-based analysis tools compared to assessment by the gold standard of mCTA and MRI (DWI and MR Angiography) assessed by neuroradiologists. 2. To assess if the use of available AI-based analysis tools applied to mCTA can increase the number of stroke patients eligible for and offered EVT. 3. To assess if the use of AI-based image analysis tools in radiological diagnostics in primary stroke centres can reduce the time from onset to recanalization in acute ischemic stroke patients treated with EVT. 4. To compare functional outcome and patient related outcome measures 3 months after EVT in stroke patients who had their initial radiological diagnosis using AI-based image analysis tools to stroke patients diagnosed by standard care. Number of subjects: 300 Study centers: Oslo University Hospital, Vestre Viken Hospital and Østfold Hospital Trust. Duration of Study participation: - Enrollment: 24 months - Follow-up: 3 months - Total study duration 27 months Primary Endpoints: - Time from the start of CT scan of patients at the local hospital to radiological diagnosis in acute stroke patients with LVO and MeVO in periods with the use of AI software compared to periods with standard care. Secondary endpoints: - Time from the start of CT scan of patients at the local hospital to start of thrombectomy in patients identified with LVO and MeVO in periods with the use of AI software compared to periods with standard care. - Time from symptom onset to start of thrombectomy in patients identified with LVO and MeVO in periods with the use of AI software compared with proportion of patients identified with LVO and MeVO diagnosed by standard care. - Proportion of patients identified with LVO and MeVO in periods with the use of AI software compared with proportion of patients identified with LVO and MeVO diagnosed by standard care. - Proportion of patients identified with LVO and MeVO in periods with the use of AI software compared to assessment by neuroradiologists. - Proportion of patients treated with thrombectomy in MeVO in periods with the use of AI software compared with proportion of patients identified with LVO and MeVO diagnosed by standard care. - Functional outcome 3 months after EVT in stroke patients who had their initial radiological diagnosis using AI-based image analysis tools compared to stroke patients diagnosed by standard care. - Patient related outcome measures 3 months after EVT in stroke patients who had their initial radiological diagnosis using AI-based image analysis tools compared to stroke patients diagnosed by standard care. The baseline registration period started in December 2021. Due to delays from Sykehuspartner the start-up of the the implementation of AI-based tools in the assessment of medium and large vessel occlusion and selection of candidates for thrombectomy in Østfold Hospital Trust started autumn 2023 and in different hospitals in Vestre Viken Hospital Trust by the turn of the year and Lillehammer is planning to start in 2024. The project is coordinated with a parallell project in the Northern Norway Regional Health Authority, involving all hospitals in the northern region.

None

2022
The main aim of the this prospective observational multi-center study is to organize and simplify the care pathway through a pragmatic approach to acute stroke imaging powered by cutting edge advances in image processing and artificial intelligence. The project is led from Oslo UH in collaboration with Østfold and Vestre Viken Hospital Trust.Secondary aims: 1. To assess the diagnostic accuracy of mCTA in detection of medium and large vessel occlusion ischemic stroke using AI-based analysis tools compared to assessment by the gold standard of mCTA and MRI (DWI and MR Angiography) assessed by neuroradiologists. 2. To assess if the use of available AI-based analysis tools applied to mCTA can increase the number of stroke patients eligible for and offered EVT. 3. To assess if the use of AI-based image analysis tools in radiological diagnostics in primary stroke centres can reduce the time from onset to recanalization in acute ischemic stroke patients treated with EVT. 4. To compare functional outcome and patient related outcome measures 3 months after EVT in stroke patients who had their initial radiological diagnosis using AI-based image analysis tools to stroke patients diagnosed by standard care. Number of subjects: 300 Study centers: Oslo University Hospital, Vestre Viken Hospital and Østfold Hospital Trust. Duration of Study participation: - Enrollment: 24 months - Follow-up: 3 months - Total study duration 27 months Primary Endpoints: - Time from the start of CT scan of patients at the local hospital to radiological diagnosis in acute stroke patients with LVO and MeVO in periods with the use of AI software compared to periods with standard care. Secondary endpoints: - Time from the start of CT scan of patients at the local hospital to start of thrombectomy in patients identified with LVO and MeVO in periods with the use of AI software compared to periods with standard care. - Time from symptom onset to start of thrombectomy in patients identified with LVO and MeVO in periods with the use of AI software compared with proportion of patients identified with LVO and MeVO diagnosed by standard care. - Proportion of patients identified with LVO and MeVO in periods with the use of AI software compared with proportion of patients identified with LVO and MeVO diagnosed by standard care. - Proportion of patients identified with LVO and MeVO in periods with the use of AI software compared to assessment by neuroradiologists. - Proportion of patients treated with thrombectomy in MeVO in periods with the use of AI software compared with proportion of patients identified with LVO and MeVO diagnosed by standard care. - Functional outcome 3 months after EVT in stroke patients who had their initial radiological diagnosis using AI-based image analysis tools compared to stroke patients diagnosed by standard care. - Patient related outcome measures 3 months after EVT in stroke patients who had their initial radiological diagnosis using AI-based image analysis tools compared to stroke patients diagnosed by standard care. The baseline registration period started in December 2021. Due to delays from Sykehuspartner we are still waiting for the start-up of the the implementation of AI-based tools in the assessment of medium and large vessel occlusion and selection of candidates for thrombectomy in Vestre Viken Hospital Trust. Østfold Hospital Trust has been recruited to strengthen the inclusion. The project is coordinated with a parallell project in the Northern Norway Regional Health Authority, involving all hospitals in the northern region.

nei

2021
The main aim of the this prospective observational multi-center study is to organise and simplify the care pathway through a pragmatic approach to acute stroke imaging powered by cutting edge advances in image processing and artificial intelligence.Secondary aims: 1. To assess the diagnostic accuracy of mCTA in detection of medium and large vessel occlusion ischemic stroke using AI-based analysis tools compared to assessment by the gold standard of mCTA and MRI (DWI and MR Angiography) assessed by neuroradiologists. 2. To assess if the use of available AI-based analysis tools applied to mCTA can increase the number of stroke patients eligible for and offered EVT. 3. To assess if the use of AI-based image analysis tools in radiological diagnostics in primary stroke centres can reduce the time from onset to recanalization in acute ischemic stroke patients treated with EVT. 4. To compare functional outcome and patient related outcome measures 3 months after EVT in stroke patients who had their initial radiological diagnosis using AI-based image analysis tools to stroke patients diagnosed by standard care. Number of subjects: 300 Study centers: Oslo University Hospital, Vestre Viken Hospital Trust Duration of Study participation: - Enrollment: 24 months - Follow-up: 3 months - Total study duration 27 months Primary Endpoints: - Time from the start of CT scan of patients at the local hospital to radiological diagnosis in acute stroke patients with LVO and MeVO in periods with the use of AI software compared to periods with standard care. Secondary endpoints: - Time from the start of CT scan of patients at the local hospital to start of thrombectomy in patients identified with LVO and MeVO in periods with the use of AI software compared to periods with standard care. - Time from symptom onset to start of thrombectomy in patients identified with LVO and MeVO in periods with the use of AI software compared with proportion of patients identified with LVO and MeVO diagnosed by standard care. - Proportion of patients identified with LVO and MeVO in periods with the use of AI software compared with proportion of patients identified with LVO and MeVO diagnosed by standard care. - Proportion of patients identified with LVO and MeVO in periods with the use of AI software compared to assessment by neuroradiologists. - Proportion of patients treated with thrombectomy in MeVO in periods with the use of AI software compared with proportion of patients identified with LVO and MeVO diagnosed by standard care. - Functional outcome 3 months after EVT in stroke patients who had their initial radiological diagnosis using AI-based image analysis tools compared to stroke patients diagnosed by standard care. - Patient related outcome measures 3 months after EVT in stroke patients who had their initial radiological diagnosis using AI-based image analysis tools compared to stroke patients diagnosed by standard care. The 6-months baseline registration period started in December 2021. After 6 months the implementation of AI-based tools in the assessment of medium and large vessel occlusion and selection of candidates for thrombectomy will be implemented.

nei

Vitenskapelige artikler
Enriquez BAB, Nome T, Nome CG, Tennøe B, Lund CG, Beyer MK, Skjelland M, Aamodt AH

Predictors of outcome after endovascular treatment for tandem occlusions: a single center retrospective analysis.

BMC Neurol 2023 Feb 27;23(1):82. Epub 2023 feb 27

PMID: 36849925

Bendszus M, Fiehler J, Subtil F, Bonekamp S, Aamodt AH, Fuentes B, Gizewski ER, Hill MD, Krajina A, Pierot L, Simonsen CZ, Zelenák K, Blauenfeldt RA, Cheng B, Denis A, Deutschmann H, Dorn F, Flottmann F, Gellißen S, Gerber JC, Goyal M, Haring J, Herweh C, Hopf-Jensen S, Hua VT, Jensen M, Kastrup A, Keil CF, Klepanec A, Kurca E, Mikkelsen R, Möhlenbruch M, Müller-Hülsbeck S, Münnich N, Pagano P, Papanagiotou P, Petzold GC, Pham M, Puetz V, Raupach J, Reimann G, Ringleb PA, Schell M, Schlemm E, Schönenberger S, Tennøe B, Ulfert C, Vališ K, Vítková E, Vollherbst DF, Wick W, Thomalla G,

Endovascular thrombectomy for acute ischaemic stroke with established large infarct: multicentre, open-label, randomised trial.

Lancet 2023 Nov 11;402(10414):1753. Epub 2023 okt 11

PMID: 37837989

Avan A, Aamodt AH, Selbaek G, Bovim G, Bassetti CLA, Boon P, Grisold W, Hachinski V

Decreasing incidence of stroke, ischaemic heart disease and dementia in Norway, 1990-2019, a Global Burden of Disease study: an opportunity.

Eur J Neurol 2023 Aug;30(8):2267. Epub 2023 mai 21

PMID: 37154405

Enriquez BA, Tennøe B, Nome T, Gjertsen Ø, Nedregaard B, Sletteberg R, Skattør T, Sökjer M, Johansen H, Skagen KR, Skjelland M, Aamodt AH, Lund CG

[Mechanical thrombectomy in acute ischaemic stroke].

Tidsskr Nor Laegeforen 2022 May 03;142(7). Epub 2022 mai 2

PMID: 35510464

Enriquez BA, Nome T, Nome CG, Tennøe B, Lund CG, Beyer MK, Skjelland M, Aamodt AH

Predictors of outcome after endovascular treatment for Tandem Occlusions: a single center retrospective analysis

Research Square, 07 Jul 2022

Deltagere
  • Jostein Gleditsch Prosjektdeltaker
  • Dag Ottar Sætre Prosjektdeltaker
  • Anette Huuse Farmen Prosjektdeltaker
  • Ragnhild Munthe-Kaas Prosjektdeltaker
  • Harald Bergan Prosjektdeltaker
  • Anne Hege Aamodt Prosjektleder
  • Agnethe Eltoft Forsker (annen finansiering)
  • Jon-André Totland Forsker (annen finansiering)
  • Linn Heitmann Forsker (annen finansiering)
  • Mayank Goyal Internasjonal samarbeidspartner
  • Anniken Haslund Prosjektdeltaker
  • Bjørn Anton Graff Prosjektdeltaker
  • Ingvild Nakstad Prosjektdeltaker
  • Atle Bjørnerud Medveileder
  • Mona Kristiansen Beyer Medveileder
  • Thor Håkon Skattør Doktorgradsstipendiat (finansiert av denne bevilgning)
  • Brian Enriquez Prosjektdeltaker

eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT

Alle henvendelser rettes til eRapport

Personvern  -  Informasjonskapsler